Global  

Oxycodone

Opioid medication

Oxycodone    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Oxycodone: Opioid medication
Oxycodone, sold under the brand name OxyContin among others, is an opioid medication used for treatment of moderate to severe pain, and a common drug of abuse. It is usually taken by mouth, and is available in immediate-release and controlled-release formulations. Onset of pain relief typically begins within fifteen minutes and lasts for up to six hours with the immediate-release formulation. In the United Kingdom, it is available by injection. Combination products are also available with paracetamol (acetaminophen), ibuprofen, naloxone, and aspirin.

0
shares
ShareTweetSavePostSend
 

OxyContin Maker Purdue Pharma to Plead Guilty to 3 Federal Charges [Video]

OxyContin Maker Purdue Pharma to Plead Guilty to 3 Federal Charges

Justice Department officials made the announcement on Wednesday.

Credit: Cover Video STUDIO     Duration: 01:19Published
OxyContin maker to plead guilty in opioid probe [Video]

OxyContin maker to plead guilty in opioid probe

Purdue Pharma agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, in a deal that comes with a $8.4 billion settlement but stops short of..

Credit: Reuters Studio     Duration: 02:37Published
DOJ announces Purdue Pharma's plea deal in opioid probe [Video]

DOJ announces Purdue Pharma's plea deal in opioid probe

Purdue Pharma LP agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, in a deal with U.S. prosecutors that imposed significant penalties..

Credit: Reuters Studio     Duration: 02:10Published

You Might Like


Opioid crisis: OxyContin maker Purdue Pharma to plead to 3 criminal charges

opioid crisis: oxycontin maker purdue pharma to plead to 3 criminal charges
Drugmaker Purdue Pharma, the company behind the powerful prescription painkiller OxyContin that experts say helped touch off an opioid epidemic, will plead guilty to federal criminal charges as part of..
New Zealand Herald - Published

Where the Purdue Pharma-Sackler legal saga stands

OxyContin maker Purdue Pharma LP and its controlling Sackler family have been negotiating with cities, counties and states on a proposed settlement worth an estimated $10 billion to resolve more than..
Reuters - Published

Exclusive: OxyContin maker Purdue is 'Pharma Co X' in U.S. opioid kickback probe - sources

OxyContin maker Purdue Pharma LP is the unnamed company that surfaced in criminal charging documents filed earlier this week in a probe of illegal kickbacks from drugmakers, according to people..
Reuters - Published

Tufts University removes Sackler sign from bldg

A maintenance worker has used a hammer and a flexible wall scrapper to remove the name of the billionaire family that owns OxyContin maker Purdue Pharma from a Tufts University building. (Dec. 5)  
USATODAY.com - Published

OxyContin maker Purdue Pharma to pay states' lawyers, urged to help victims

OxyContin maker Purdue Pharma LP got court approval on Tuesday to reimburse millions of dollars in legal fees for states that back its proposed $10 billion settlement of opioid lawsuits, but with a..
Reuters - Published

OxyContin maker Purdue gets brief shield from litigation

OxyContin maker Purdue Pharma LP won a court order on Friday briefly pausing the sprawling opioid litigation against the company so it can try to make headway on its proposed legal settlement that it..
Reuters - Published

Judge sees benefit in pausing lawsuits against OxyContin maker Purdue

A U.S. Bankruptcy Judge signaled support on Friday for a six-month pause to litigation led by 24 states against OxyContin maker Purdue Pharma LP to give the company time to settle thousands of lawsuits..
Reuters - Published

U.S. judge urges parties to wisely use Purdue opioid settlement funds

A U.S. bankruptcy judge on Thursday urged parties that will benefit from a proposed settlement with OxyContin maker Purdue Pharma LP to focus on addressing the opioid addiction crisis and avoid..
Reuters - Published

Sacklers reaped up to $13 billion from OxyContin maker, U.S. states say

OxyContin maker Purdue Pharma LP steered up to $13 billion in profits to the company's controlling Sackler family, according to U.S. states opposing efforts to halt lawsuits alleging the company and..
Reuters - Published

U.S. states fight back against Purdue's bid to halt opioid lawsuits

U.S. state officials are due on Friday to launch a counterattack against OxyContin maker Purdue Pharma LP over its attempt to shield the company and its controlling Sackler family from thousands of..
Reuters - Published

Purdue Pharma seeks to halt opioid suits against company, Sacklers

OxyContin maker Purdue Pharma LP on Wednesday asked a U.S. bankruptcy judge to halt for roughly nine months more than 2,600 lawsuits alleging the company and its controlling Sackler family helped fuel..
Reuters - Published

Oxycontin maker Purdue begins bankruptcy in push to settle opioid lawsuits

OxyContin maker Purdue Pharma LP is expected in court on Tuesday to lay out its plan for using bankruptcy to resolve more than 2,600 lawsuits alleging the company fueled the U.S. opioid crisis.
Reuters - Published

What's next for OxyContin maker Purdue Pharma

OxyContin maker Purdue Pharma LP filed for bankruptcy protection after reaching a partial deal to resolve more than 2,600 lawsuits alleging it helped fuel the U.S. opioid crisis.
Reuters - Published

OxyContin maker Purdue Pharma files for bankruptcy amid opioid crisis

OxyContin maker Purdue Pharma LP filed for bankruptcy protection Sunday night, succumbing to pressure from more than 2,600 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic.
France 24 - Published Also reported by •USATODAY.comReuters

AP Top Stories September 16

Here's the latest for Monday September 16th: 49,000 UAW members strike against GM; Oil prices spike after attack in Saudi Arabia; Oxycontin maker Purdue Pharma files for bankruptcy; more.  
USATODAY.com - Published

NY finds $1B in hidden transfers by family behind OxyContin

ny finds $1b in hidden transfers by family behind oxycontin
NEW YORK (AP) — The family that owns OxyContin maker Purdue Pharma used Swiss and other hidden accounts to transfer $1 billion to themselves, New York’s attorney general contends in court papers..
WorldNews - Published

Eye Opener: The Trump administration moves to ban most flavored e-cigarettes

President Trump proposes a ban on most flavored vaping products. Also, 23 states have reached a tentative settlement with OxyContin maker Purdue Pharma over the nation’s opioid crisis. All that and..
CBS News - Published

Purdue Pharma reaches tentative opioid settlement with some: sources

OxyContin maker Purdue Pharma LP reached a tentative agreement with some plaintiffs to resolve litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states..
Reuters - Published

Purdue OxyContin settlement would rank among largest in pharma history

OxyContin maker Purdue Pharma LP has reached a tentative multibillion-dollar agreement with some plaintiffs aimed at settling thousands of lawsuits over its alleged role in the U.S. opioid crisis,..
Reuters - Published

Exclusive: Purdue Pharma nears partial opioid settlement, bankruptcy filing - sources

OxyContin maker Purdue Pharma LP is nearing a partial agreement to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing its..
Reuters - Published

Exclusive: OxyContin maker prepares 'free-fall' bankruptcy as settlement talks stall

OxyContin maker Purdue Pharma LP is preparing to seek bankruptcy protection before the end of the month if it does not reach a settlement with U.S. communities over widespread opioid litigation, three..
Reuters - Published

US firm Purdue Pharma 'offers up to $12 billion' to settle opioid lawsuits

OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion, two people familiar..
France 24 - Published Also reported by •BBC NewsReuters

Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion, two people familiar..
Reuters - Published

OxyContin maker Purdue Pharma reportedly offering opioid settlement up to $12B

OxyContin maker Purdue Pharma is reportedly offering a settlement worth up to $12 billion to resolve claims over its role in the opioid crisis.
USATODAY.com - Published